TSC2 and lymphangioleiomyomatosis: Sequencing of tissue from LAM nodules or disseminated LAM cells from body fluids has indicated that germline TSC1 or TSC2 mutations are not prevalent in S-LAM patients (Astrinidis et al., 2000; Carsillo et al., 2000).